Qiagen to Work with NCI on siRNA Development …
Qiagen said this week that it has struck a deal with the National Cancer Institute to develop a validated set of siRNAs for use by NCI researchers.
According to the company, the siRNAs will be made available to the general research community after characterization work is complete.
Additional terms of the arrangement were not disclosed.
… And Announces Acqusition of Diagnostics Firm Artus